toxic efficaci anti-t-cel ricin toxin chain immunotoxin murin model graft-versus-host diseas major histocompat barrier graft-versus-host diseas gvhd murin major histocompat complex bone marrow murin recipi immunotoxin IT pan t-cell monoclon antibodi murin homologu human toxin chain recipi mice vitro IT activ free rta bound t-cell prolifer absenc potenti mice vivo gvhd dose micrograms/d day number splenic cell surviv mice phosphate-buff salin pb irrelev control rta IT protect transient gvhd weight loss inject surviv low oligosaccharide-contain fraction purifi rta treatment signific elev neutrophil dose mild hepatotox contrast infus ident dose schedul pan t-cell immunotoxin signific decreas lymphocyt neutrophil precipit increas weight decreas total plasma protein tpp increas pleural periton effus reminisc vascular leak syndrom vl toxic effect sever surviv advantag gvhd model histopatholog studi definit anti-gvhd effect signific declin gvhd pbs-treat control skin extent liver lung caus IT toxic irradi recipi syngen bone marrow recipi weight gain hypoproteinuria vl gvhd model death dose micrograms/daili inject day posttranspl neglig effect renal function histolog studi patchi dropout renal tubul treatment pulmonari vascular congest patholog evid liver brain colon toxic weight gain irradi normal mice precipit weight increas abstract truncat AT word 